Clinical Trial Update: Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the safety of a recombinant acellular pertussis vaccine in adults; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• Recombinant Acellular Pertussis Vaccine (pertussis vaccine, recombinant acellular)

Snippet

Sponsor: BioNet-Asia Co., Ltd. | Conditions: Pertussis Vaccine | Phase 3 | Status: ACTIVE_NOT_RECRUITING